tradingkey.logo

Merit Medical Systems Inc

MMSI
82.500USD
+2.870+3.60%
Close 02/06, 16:00ETQuotes delayed by 15 min
4.89BMarket Cap
41.08P/E TTM

Merit Medical Systems Inc

82.500
+2.870+3.60%

More Details of Merit Medical Systems Inc Company

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.

Merit Medical Systems Inc Info

Ticker SymbolMMSI
Company nameMerit Medical Systems Inc
IPO dateOct 22, 2090
CEOAronson (Martha Goldberg)
Number of employees7400
Security typeOrdinary Share
Fiscal year-endOct 22
Address1600 West Merit Park Way
CitySOUTH JORDAN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code84095
Phone18012531600
Websitehttps://www.merit.com/
Ticker SymbolMMSI
IPO dateOct 22, 2090
CEOAronson (Martha Goldberg)

Company Executives of Merit Medical Systems Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-60000.00%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+2152.00%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-17293.00%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
+19594.00%
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+2152.00%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+2152.00%
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
16.61K
--
Rear Adm. (Retd.) Stephen C. Evans
Rear Adm. (Retd.) Stephen C. Evans
Independent Director
Independent Director
6.81K
+2152.00%
Mr. Michael R. (Mike) McDonnell, CPA
Mr. Michael R. (Mike) McDonnell, CPA
Independent Director
Independent Director
3.96K
-1750.00%
Dr. F. Ann Millner, Ed.D.
Dr. F. Ann Millner, Ed.D.
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-60000.00%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+2152.00%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-17293.00%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
+19594.00%
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+2152.00%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+2152.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Peripheral Intervention
144.78M
37.69%
Cardiac Intervention
116.68M
30.37%
Custom Procedural Solutions
54.14M
14.09%
OEM
50.83M
13.23%
Endoscopy devices
17.73M
4.62%
By RegionUSD
Name
Revenue
Proportion
United States
230.60M
60.03%
International
153.56M
39.97%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Peripheral Intervention
144.78M
37.69%
Cardiac Intervention
116.68M
30.37%
Custom Procedural Solutions
54.14M
14.09%
OEM
50.83M
13.23%
Endoscopy devices
17.73M
4.62%

Shareholding Stats

Updated: Sun, Jan 11
Updated: Sun, Jan 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.08%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.52%
Fuller & Thaler Asset Management Inc.
3.11%
Other
65.24%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.08%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.52%
Fuller & Thaler Asset Management Inc.
3.11%
Other
65.24%
Shareholder Types
Shareholders
Proportion
Investment Advisor
54.86%
Investment Advisor/Hedge Fund
32.69%
Hedge Fund
10.11%
Research Firm
3.04%
Bank and Trust
2.41%
Individual Investor
2.26%
Pension Fund
1.62%
Sovereign Wealth Fund
1.02%
Family Office
0.59%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
761
62.82M
105.96%
-4.06M
2025Q3
736
64.29M
108.43%
-3.60M
2025Q2
756
65.62M
110.80%
-760.05K
2025Q1
779
66.66M
112.79%
+221.37K
2024Q4
755
63.98M
108.78%
+576.77K
2024Q3
725
62.16M
106.75%
-1.49M
2024Q2
695
63.02M
108.42%
-345.52K
2024Q1
677
61.08M
105.16%
-692.46K
2023Q4
651
59.77M
103.51%
-88.47K
2023Q3
637
57.87M
100.40%
-723.38K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
7.91M
13.34%
-62.52K
-0.78%
Sep 30, 2025
The Vanguard Group, Inc.
6.63M
11.18%
-186.32K
-2.73%
Sep 30, 2025
State Street Investment Management (US)
2.20M
3.71%
-19.84K
-0.89%
Sep 30, 2025
Conestoga Capital Advisors, LLC
2.19M
3.69%
-26.32K
-1.19%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
1.84M
3.11%
+23.74K
+1.30%
Sep 30, 2025
Maverick Capital, Ltd.
1.61M
2.72%
+230.81K
+16.73%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.45M
2.45%
+14.55K
+1.01%
Sep 30, 2025
Nomura Investment Management Business Trust
1.33M
2.25%
-124.75K
-8.57%
Sep 30, 2025
Wellington Management Company, LLP
1.24M
2.09%
+980.82K
+377.70%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.18M
1.99%
+68.71K
+6.19%
Sep 30, 2025
View more

Related ETFs

Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Invesco S&P SmallCap Health Care ETF
3.18%
First Trust Indxx Medical Devices ETF
2.22%
State Street SPDR S&P Health Care Equipment ETF
1.76%
Thrivent Small-Mid Cap ESG ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
0.71%
OneAscent Enhanced Small and Mid Cap ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.67%
iShares S&P Small-Cap 600 Growth ETF
0.66%
Franklin US Small Cap Multifactor Index ETF
0.66%
View more
Invesco S&P SmallCap Health Care ETF
Proportion3.18%
First Trust Indxx Medical Devices ETF
Proportion2.22%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.76%
Thrivent Small-Mid Cap ESG ETF
Proportion0.91%
Invesco S&P SmallCap Low Volatility ETF
Proportion0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
Proportion0.71%
OneAscent Enhanced Small and Mid Cap ETF
Proportion0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.67%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.66%
Franklin US Small Cap Multifactor Index ETF
Proportion0.66%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI